# A Drug-Drug Interaction Study of Digoxin and PA21

> **NCT01477411** · PHASE1 · COMPLETED · sponsor: **Vifor Pharma** · enrollment: 42 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** PA21
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT01477411
- **Lead sponsor:** Vifor Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477411, "A Drug-Drug Interaction Study of Digoxin and PA21". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01477411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*